Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

from

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

All articles

AI-Driven Compound Optimization in the Large Molecule Space

An expert interview on AI-Driven Compound Optimization in the Large Molecule Space.

Can a diverse team develop better AI? The answer is a resounding yes.

Innovation in AI starts with the people who shape it. At Merantix Momentum, we believe that diverse teams develop fairer, more effective AI - and turn inclusion into a competitive advantage.

Article

Reliable and crisis-resistant inventory optimization

Revolutionizing supply chain optimization.

Article

Clyravision: An entire forensics team in one system

Clyravision: The intelligent forensics system that not only recognizes manipulated images, but also explains exactly how and why they were altered - for more transparency and trust in the digital world.

Article

How do you make 30 years of data accessible?

In conversation with Jonas Münch, who developed a RAG chatbot at Bayer that combines 30 years of internal data and clinical results in one place.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.